Illumina, Inc. ILMN today issued the following statement regarding Roche's decision to extend for the second time its unsolicited tender offer to acquire all outstanding shares of Illumina for $44.50 in cash per common share:
"Illumina's Board of Directors continues to believe that Roche's offer is grossly inadequate, and that Illumina is positioned to create far more value than Roche has offered. Our stockholders clearly agree."
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in